Paul A Kristiansen

Summary

Affiliation: Norwegian Institute of Public Health
Country: Norway

Publications

  1. pmc Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
    Paul A Kristiansen
    WHO Collaborating Center for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 14:663. 2014
  2. doi request reprint Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
    Paul A Kristiansen
    Norwegian Institute of Public Health, University of Oslo, Norway
    Clin Infect Dis 56:354-63. 2013
  3. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
  4. pmc Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Clin Vaccine Immunol 18:435-43. 2011
  5. doi request reprint Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Trans R Soc Trop Med Hyg 106:289-97. 2012
  6. pmc Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    J Clin Microbiol 50:4020-7. 2012
  7. pmc Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine
    Dominique A Caugant
    WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    PLoS ONE 7:e46019. 2012
  8. pmc Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
    Guro K Bårnes
    WHO Collaborating Center for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 16:639. 2016
  9. pmc Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides
    Guro K Bårnes
    Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway Department of International Health, University of Oslo, Oslo, Norway
    Clin Vaccine Immunol 22:697-705. 2015
  10. doi request reprint Serogroup A meningococcal conjugate vaccines in Africa
    Paul A Kristiansen
    a 1 WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway
    Expert Rev Vaccines 14:1441-58. 2015

Collaborators

Detail Information

Publications10

  1. pmc Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
    Paul A Kristiansen
    WHO Collaborating Center for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 14:663. 2014
    ..A new multicentre carriage study was performed in October-November 2012, two years after MenAfriVac mass vaccination...
  2. doi request reprint Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
    Paul A Kristiansen
    Norwegian Institute of Public Health, University of Oslo, Norway
    Clin Infect Dis 56:354-63. 2013
    ..It is not known whether MenAfriVac has an impact on NmA carriage...
  3. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
    ..The aim of this study was to genetically characterize meningococcal isolates circulating in Burkina Faso before and up to 13 months after MenAfriVac mass vaccination...
  4. pmc Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Clin Vaccine Immunol 18:435-43. 2011
    ..5-1,2-2/F5-8, belonging to the ST-23 complex (47%). All serogroup A isolates were ST-2859 of the ST-5 complex with P1.20,9/F3-1. This study forms a solid basis for evaluating the impact of MenAfriVac introduction on serogroup A carriage...
  5. doi request reprint Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Trans R Soc Trop Med Hyg 106:289-97. 2012
    ..The overall N. meningitidis carriage prevalence (3.98%) was probably slightly underestimated and the calculated true prevalence was 4.48%. The components of the presented QC system can easily be implemented in any other laboratory study...
  6. pmc Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    J Clin Microbiol 50:4020-7. 2012
    ..meningitidis carriage and disease epidemiology in Burkina Faso...
  7. pmc Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine
    Dominique A Caugant
    WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    PLoS ONE 7:e46019. 2012
    ....
  8. pmc Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
    Guro K Bårnes
    WHO Collaborating Center for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 16:639. 2016
    ..We sought to determine the prevalence and epidemiology of meningococcal carriage in Ethiopia prior to the introduction of MenAfriVac, a serogroup A meningococcal conjugate vaccine...
  9. pmc Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides
    Guro K Bårnes
    Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway Department of International Health, University of Oslo, Oslo, Norway
    Clin Vaccine Immunol 22:697-705. 2015
    ....
  10. doi request reprint Serogroup A meningococcal conjugate vaccines in Africa
    Paul A Kristiansen
    a 1 WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway
    Expert Rev Vaccines 14:1441-58. 2015
    ....